Medical Condition News

RSS

Researchers find evidence that gout clusters in families

It's historically known as 'the king of diseases and the disease of kings' and was long thought to be caused by an overindulgent lifestyle, but now scientists at The University of Nottingham have confirmed that 'gout' strongly runs in families.

3 Dec 2013

Study: Unfolded protein response can increase risk of sudden cardiac death

A researcher at the Cardiovascular Institute (CVI) at Rhode Island, The Miriam and Newport hospitals has found a link to human heart failure that if blocked, may reduce the risk of sudden cardiac death.

3 Dec 2013

Synaptic health in the brain closely linked to cognitive decline

Age-related cognitive decline and changes in the nervous system are closely linked, but up until recently, they were thought to result from the loss of neurons in areas such as the prefrontal cortex, the part of the brain important in working memory.

3 Dec 2013

Digital breast tomosynthesis reduces recall rates and increases cancer detection

Researchers have found that digital breast tomosynthesis (DBT) led to reduced recall rates and an increase in cancer detection in a large breast cancer screening program. The results of this study were presented today at the annual meeting of the Radiological Society of North America (RSNA).

3 Dec 2013

New report on global prevalence of anemia

Despite increasing efforts to diagnose and treat anemia worldwide, there remains a surprisingly large global burden of the disease, particularly among young children and women, according to a new report on trends in anemia between 1990 and 2010.

3 Dec 2013

ATN-224 inhibitor reduces tumor sizes in mouse model of lung adenocarcinoma

Many cancers have adapted to cope with high levels of immune system-produced free radicals, also referred to as reactive oxygen species, by overproducing antioxidant proteins. One of these proteins, superoxide dismutase 1, is overproduced in lung adenocarcinomas and has been implicated as a target for chemotherapy.

3 Dec 2013

New finding links obesity and high-fat, high-sugar diets with changes in inflammatory status

Scientists have moved a step closer to an "obesity drug" that may block the effects of diets high in sugar and fats. In a new research report published in the December 2013 issue of The FASEB Journal, scientists show that there is an abnormal amount of an inflammatory protein called PAR2 in the abdominal fat tissue of overweight and obese humans and rats.

3 Dec 2013

Sports concussions increase risk of chronic traumatic encephalopathy, says study

It's been widely reported that football and other contact sports increase the risk of a debilitating neurological condition called chronic traumatic encephalopathy (CTE).

3 Dec 2013

Research show that risk of diverticulosis is lower than previously thought

People who have diverticulosis, or pouches in the lining of the colon, often worry that they will eventually develop a painful and sometimes serious condition called diverticulitis, as previous research has shown that one in four, or up to 25 percent, of those with the condition will.

3 Dec 2013

First Nations adults with diabetes more likely to face risk of end-stage kidney disease

First Nations adults with diabetes have more than double the risk of end-stage kidney disease compared with non-First Nations adults, found a new study in CMAJ (Canadian Medical Association Journal).

3 Dec 2013

New study examines micromovements to identify severity of autism spectrum disorder

Movements so minute they cannot be detected by the human eye are being analyzed by researchers to diagnose autism spectrum disorder and determine its severity in children and young adults, according to research presented at the 2013 Society for Neuroscience annual meeting in November.

3 Dec 2013

Study identifies high burden of pain in older adults

More than half of older adults in the United States - an estimated 18.7 million people - have experienced bothersome pain in the previous month, impairing their physical function and underscoring the need for public health action on pain. Many of those interviewed by investigators for a study published in the current issue of PAIN- reported pain in multiple areas.

3 Dec 2013

Scientists explain new family of proteins that appear to play key role in cancer

Scientists have described a new family of proteins that appear to play a key role in cancer and might be targets for future cancer drugs.

3 Dec 2013

Gore receives Shonin approval from Japan to market GORE C3 Delivery System

W. L. Gore & Associates, Inc. has received Shonin approval from the Japanese Ministry of Health, Labor and Welfare to market the GORE EXCLUDER AAA Endoprosthesis featuring C3 Delivery System as a minimally invasive treatment for patients suffering from an abdominal aortic aneurysm.

3 Dec 2013

Evidence reveals bronchial thermoplasty has long-term benefit for asthma patients

The beneficial effects of bronchial thermoplasty, a non-pharmacologic treatment for asthma, last at least five years, according to researchers at National Jewish Health and other institutions.

3 Dec 2013

Pfizer's Polish subsidiary acquires rights to Polocard from ZF Polpharma SA

Pfizer Inc. today announced that a wholly-owned Polish subsidiary of Pfizer has acquired the rights to Polocard, a low-dose aspirin (acidum acetylsalicylicum), and the leading over-the-counter brand for heart attack prevention in Poland, from ZF Polpharma SA.

3 Dec 2013

Forest Laboratories to acquire exclusive rights in the U.S. for Saphris sublingual tablets

Forest Laboratories Holdings Limited, a wholly owned subsidiary of Forest Laboratories, Inc. today announced that the company is acquiring exclusive rights in the United States for Saphris (asenapine) sublingual tablets, a treatment for adult patients with schizophrenia or acute bipolar mania, from Merck Sharp & Dohme B.V., a wholly owned subsidiary of Merck & Co., Inc.

3 Dec 2013

FDA extends initial PDUFA date for Biogen Idec's review of ALPROLIX BLA

Biogen Idec announced today that the U.S. Food and Drug Administration has extended the initial Prescription Drug User Fee Act date for its review of the Biologics License Application (BLA) for ALPROLIX, the company's investigational long-lasting recombinant factor IX Fc fusion protein candidate for hemophilia B.

2 Dec 2013

Vitamin D2 supplementation is promising treatment for pain, depression in type 2 diabetes

Vitamin D decreases pain in women with type 2 diabetes and depression, according to a study conducted at Loyola University Chicago. These findings were presented at an Oct. 24, 2013 research conference at Loyola's Health Sciences Campus.

2 Dec 2013

Recently discovered humanin peptide could lead to powerful new treatments for diabetes

Even if the obesity trend cannot be reversed, here's hope that it's partner in crime-diabetes-might be thwarted. New research published in the December 2013 issue of The FASEB Journal shows how a recently discovered human peptide, called humanin, could lead to powerful new treatments for some people living with diabetes.

2 Dec 2013

Medical Condition News

Researchers find evidence that gout clusters in families

Study: Unfolded protein response can increase risk of sudden cardiac death

Synaptic health in the brain closely linked to cognitive decline

Digital breast tomosynthesis reduces recall rates and increases cancer detection

New report on global prevalence of anemia

ATN-224 inhibitor reduces tumor sizes in mouse model of lung adenocarcinoma

New finding links obesity and high-fat, high-sugar diets with changes in inflammatory status

Sports concussions increase risk of chronic traumatic encephalopathy, says study

Research show that risk of diverticulosis is lower than previously thought

First Nations adults with diabetes more likely to face risk of end-stage kidney disease

New study examines micromovements to identify severity of autism spectrum disorder

Study identifies high burden of pain in older adults

Scientists explain new family of proteins that appear to play key role in cancer

Gore receives Shonin approval from Japan to market GORE C3 Delivery System

Evidence reveals bronchial thermoplasty has long-term benefit for asthma patients

Pfizer's Polish subsidiary acquires rights to Polocard from ZF Polpharma SA

Forest Laboratories to acquire exclusive rights in the U.S. for Saphris sublingual tablets

FDA extends initial PDUFA date for Biogen Idec's review of ALPROLIX BLA

Vitamin D2 supplementation is promising treatment for pain, depression in type 2 diabetes

Recently discovered humanin peptide could lead to powerful new treatments for diabetes

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News